Literature DB >> 17376760

COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys.

Corina Matzdorf1, A Kurtz, Klaus Höcherl.   

Abstract

The role of cyclooxygenase 2 (COX-2) in the control of renin is still a matter of debate, since studies with COX-2-deficient mice or with COX-2 inhibitors produced conflicting findings. Therefore, we studied the effect of the COX-2 inhibitor SC-58236 on the regulation of the renin system in adult rat kidneys. Renocortical tissue levels and urinary excretion of PGE(2) were reduced to 65 and 40% of control values, respectively, after a single gavage of SC-58236 and did not further decrease on prolonged treatment. Plasma renin activity (PRA) and renin mRNA levels began to decrease after 3 days and reached a constant level of approximately 60% of control values after 5 days of treatment. Isoproterenol or left renal artery clipping for 2 days increased PRA and renin mRNA to similar levels in both vehicle- and SC-58236-treated rats after 2 days. Pretreatment with SC-58236 for 5 days, however, reduced the absolute increase in PRA and renin mRNA levels. Notably, the relative increases were not different between vehicle- and SC-58236-treated rats. Similar findings were observed for the stimulation of the renin system by angiotensin II inhibition and low salt intake. These findings indicate that COX-2 inhibition attenuates renin secretion and renin gene expression stimulated by a variety of parameters in proportion to the lowering of basal renin activity, while it does not interfere with the different stimulatory mechanism per se. As a consequence, it appears as if COX-2 activity relevantly determines the set point of the activity of the renin system in rat kidneys.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376760     DOI: 10.1152/ajprenal.00513.2006

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  17 in total

1.  Functional expression of the olfactory signaling system in the kidney.

Authors:  Jennifer L Pluznick; Dong-Jing Zou; Xiaohong Zhang; Qingshang Yan; Diego J Rodriguez-Gil; Christoph Eisner; Erika Wells; Charles A Greer; Tong Wang; Stuart Firestein; Jurgen Schnermann; Michael J Caplan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

2.  Prostaglandin E2 EP3 receptor regulates cyclooxygenase-2 expression in the kidney.

Authors:  Carlos P Vio; Mariana Quiroz-Munoz; Catherina A Cuevas; Carlos Cespedes; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-23

3.  Macula densa sensing and signaling mechanisms of renin release.

Authors:  János Peti-Peterdi; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2010-04-01       Impact factor: 10.121

4.  Endothelium-derived nitric oxide supports renin cell recruitment through the nitric oxide-sensitive guanylate cyclase pathway.

Authors:  Björn Neubauer; Katharina Machura; Ramona Kettl; Maria Luisa S Sequeira Lopez; Andreas Friebe; Armin Kurtz
Journal:  Hypertension       Date:  2013-01-07       Impact factor: 10.190

Review 5.  The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function.

Authors:  Torrance Green; Alexis A Gonzalez; Kenneth D Mitchell; L Gabriel Navar
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

Review 6.  Loop Diuretics in the Treatment of Hypertension.

Authors:  Line Malha; Samuel J Mann
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

7.  Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary system.

Authors:  Joseph Azzarello; Kar-Ming Fung; Hsueh-Kung Lin
Journal:  J Histochem Cytochem       Date:  2008-06-23       Impact factor: 2.479

8.  Physiologic and pathophysiologic roles of cyclooxygenase-2 in the kidney.

Authors:  Raymond C Harris
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

9.  Development of vascular renin expression in the kidney critically depends on the cyclic AMP pathway.

Authors:  Björn Neubauer; Katharina Machura; Min Chen; Lee S Weinstein; Mona Oppermann; Maria Luisa Sequeira-Lopez; R Ariel Gomez; Jürgen Schnermann; Hayo Castrop; Armin Kurtz; Charlotte Wagner
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-04

10.  Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome.

Authors:  Anne Blanchard; Rosa Vargas-Poussou; Marion Vallet; Aurore Caumont-Prim; Julien Allard; Estelle Desport; Laurence Dubourg; Matthieu Monge; Damien Bergerot; Stéphanie Baron; Marie Essig; Frank Bridoux; Ivan Tack; Michel Azizi
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.